Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byAmgen
Price$10.5B
Date8/2013

General Information

Websiteonyx-pharm.com
CategoryBioTech
Phone+1 (650) 266-0000
Employees
Founded1992

Offices

South San Francisco, USA

People

Co-Founder
Board of Directors

Acquisitions

Proteolix, 10/2009

Tags

Onyx Pharmaceuticals

Onyx Pharmaceuticals is a biopharmaceutical company committed to improving the lives of people with cancer. Their lead product is Nexavar (sorafenib), a novel, oral multiple kinase inhibitor that targets proteins involved in both tumor cell proliferation and angiogenesis.

Recent Milestones

Videos

Screenshots

Onyx Pharmaceuticals screenshot
Above: Onyx Pharmaceuticals
Uploaded: 10/13/09

Sources

  1. Amgen Said to Be Near Deal to Buy Onyx for $10.5 Billion (dealbook.nytimes.com) [edit]
  2. Onyx strikes $851M deal to buy Proteolix (fiercebiotech.com) [edit]
Edit This Page
Last Edited 4/8/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy